Ikarian Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-62,052
| Closed | -$2.43M | – | 176 |
|
|
2024
Q4 | $2.43M | Sell |
62,052
-45,135
| -42% | -$1.77M | 0.33% | 41 |
|
|
2024
Q3 | $4.22M | Hold |
107,187
| – | – | 0.59% | 27 |
|
|
2024
Q2 | $4.18M | Hold |
107,187
| – | – | 0.73% | 21 |
|
|
2024
Q1 | $4.61M | Buy |
+107,187
| New | +$4.61M | 0.51% | 28 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 126 |
|
|
2023
Q3 | – | Sell |
-135,486
| Closed | -$5.22M | – | 120 |
|
|
2023
Q2 | $5.22M | Sell |
135,486
-25,000
| -16% | -$963K | 0.83% | 17 |
|
|
2023
Q1 | $5.74M | Hold |
160,486
| – | – | 1.3% | 14 |
|
|
2022
Q4 | $6.33M | Hold |
160,486
| – | – | 1.53% | 13 |
|
|
2022
Q3 | $5.79M | Sell |
160,486
-78,955
| -33% | -$2.85M | 1.15% | 13 |
|
|
2022
Q2 | $7.28M | Hold |
239,441
| – | – | 1.33% | 13 |
|
|
2022
Q1 | $7.32M | Buy |
239,441
+60,303
| +34% | +$1.84M | 0.96% | 11 |
|
|
2021
Q4 | $5.6M | Sell |
179,138
-198,300
| -53% | -$6.2M | 0.83% | 18 |
|
|
2021
Q3 | $5.77M | Sell |
377,438
-263,168
| -41% | -$4.02M | 0.41% | 20 |
|
|
2021
Q2 | $11.9M | Buy |
640,606
+30
| +0% | +$559 | 0.96% | 10 |
|
|
2021
Q1 | $11.5M | Buy |
640,576
+417,403
| +187% | +$7.47M | 0.39% | 11 |
|
|
2020
Q4 | $3.43M | Hold |
223,173
| – | – | 0.15% | 51 |
|
|
2020
Q3 | $2.47M | Sell |
223,173
-75,000
| -25% | -$830K | 0.18% | 52 |
|
|
2020
Q2 | $3.74M | Sell |
298,173
-145,409
| -33% | -$1.82M | 0.3% | 32 |
|
|
2020
Q1 | $5.03M | Buy |
443,582
+200,112
| +82% | +$2.27M | 0.38% | 20 |
|
|
2019
Q4 | $3.19M | Buy |
+243,470
| New | +$3.19M | 0.52% | 13 |
|